Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows

v3.23.3
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended
Oct. 31, 2023
Oct. 31, 2022
Cash flows from operating activities:    
Net loss $ (6,616) $ (10,635)
Adjustments to reconcile net loss to net cash used in operating activities:    
Change in fair value of convertible debentures 328
Depreciation and amortization of property, plant and equipment 270 780
Amortization of intangible, prepaid and other assets 22
Share-based compensation charges 1,075 430
Share-based 401(k) employer match expense 109 198
Unrealized foreign exchange loss 970 783
Changes in operating assets and liabilities:    
Accounts receivable 2,019 (11)
Inventories 428 (393)
Prepaid expenses and other assets 346 666
Accounts payable – trade (5,601) (407)
Accrued liabilities, other current liabilities and other liabilities (6,702) (126)
Total adjustments (6,758) 1,942
Net cash used in operating activities (13,374) (8,693)
Cash flows from investing activities:    
Capital expenditures (254) (652)
Net cash used in investing activities (254) (652)
Cash flows from financing activities:    
Repayments under mortgage agreement and capital leases (51) (95)
Cash payments for taxes related to net share settlements of equity awards (467)
Net cash used in financing activities (518) (95)
Effect of exchange rate changes on cash and cash equivalents (20) (28)
Decrease in cash and cash equivalents and restricted cash (14,166) (9,468)
Cash and cash equivalents and restricted cash - beginning of period 83,373 22,603
Cash and cash equivalents and restricted cash - end of period 69,207 13,135
Composition of cash and cash equivalents and restricted cash is as follows:    
Cash and cash equivalents 69,207 12,135
Restricted cash 1,000
Total cash and cash equivalents and restricted cash $ 69,207 $ 13,135